127 related articles for article (PubMed ID: 32732841)
21. Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts.
OʼLeary JG; Demetris AJ; Philippe A; Freeman R; Cai J; Heidecke H; Smith C; Hart B; Jennings LW; Catar R; Everly M; Klintmalm GB; Dragun D
Transplantation; 2017 Oct; 101(10):2399-2409. PubMed ID: 28665894
[TBL] [Abstract][Full Text] [Related]
22. Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis.
Philogene MC; Amin A; Zhou S; Charnaya O; Vega R; Desai N; Neu AM; Pruette CS
Pediatr Nephrol; 2020 Jan; 35(1):83-94. PubMed ID: 31599339
[TBL] [Abstract][Full Text] [Related]
23. Donor-Specific HLA Antibodies in Living Versus Deceased Donor Liver Transplant Recipients.
Levitsky J; Kaneku H; Jie C; Walsh RC; Abecassis M; Tambur AR
Am J Transplant; 2016 Aug; 16(8):2437-44. PubMed ID: 26896194
[TBL] [Abstract][Full Text] [Related]
24. The Significance of Screening for HLA Antibodies in the Long-Term Follow-up of Pediatric Liver Transplant Recipients.
Tokodai K; Kawagishi N; Miyagi S; Nakanishi C; Hara Y; Fujio A; Kashiwadate T; Maida K; Goto H; Kamei T; Ohuchi N
Transplant Proc; 2016 May; 48(4):1139-41. PubMed ID: 27320574
[TBL] [Abstract][Full Text] [Related]
25. Antibody-mediated rejection in pediatric liver transplant recipients.
Markiewicz-Kijewska M; Kaliciński P; Kluge P; Piątosa B; Rękawek A; Jankowska I; Kostecka E; Kurowski PN
Ann Transplant; 2014 Mar; 19():119-23. PubMed ID: 24594760
[TBL] [Abstract][Full Text] [Related]
26. Unique molecular changes in kidney allografts after simultaneous liver-kidney compared with solitary kidney transplantation.
Taner T; Park WD; Stegall MD
Kidney Int; 2017 May; 91(5):1193-1202. PubMed ID: 28233612
[TBL] [Abstract][Full Text] [Related]
27. Not All Cellular Rejections Are the Same: Differences in Early and Late Hepatic Allograft Rejection.
Jadlowiec CC; Morgan PE; Nehra AK; Hathcock MA; Kremers WK; Heimbach JK; Wiesner RH; Taner T
Liver Transpl; 2019 Mar; 25(3):425-435. PubMed ID: 30615251
[TBL] [Abstract][Full Text] [Related]
28. Prospective Monitoring of Donor-specific Anti-HLA Antibodies After Intestine/Multivisceral Transplantation: Significance of De Novo Antibodies.
Kubal C; Mangus R; Saxena R; Lobashevsky A; Higgins N; Fridell J; Tector AJ
Transplantation; 2015 Aug; 99(8):e49-56. PubMed ID: 25769071
[TBL] [Abstract][Full Text] [Related]
29. Identification of liver transplant biopsy phenotypes associated with distinct liver biological markers and allograft survival.
Demir Z; Raynaud M; Aubert O; Debray D; Sebagh M; Duong Van Huyen JP; Del Bello A; Jolivet NC; Paradis V; Durand F; Muratot S; Lozach C; Chardot C; Francoz C; Kamar N; Sarnacki S; Coilly A; Samuel D; Vibert E; Féray C; Lefaucheur C; Loupy A
Am J Transplant; 2024 Jun; 24(6):954-966. PubMed ID: 38097016
[TBL] [Abstract][Full Text] [Related]
30. Donor specific HLA antibodies & allograft injury: mechanisms, methods of detection, manifestations and management.
McCaughan JA; Tinckam KJ
Transpl Int; 2018 Oct; 31(10):1059-1070. PubMed ID: 30062683
[TBL] [Abstract][Full Text] [Related]
31. Non-invasive screening for subclinical liver graft injury in adults via donor-specific anti-HLA antibodies.
Höfer A; Jonigk D; Hartleben B; Verboom M; Hallensleben M; Manns MP; Jaeckel E; Taubert R
Sci Rep; 2020 Aug; 10(1):14242. PubMed ID: 32859929
[TBL] [Abstract][Full Text] [Related]
32. The Utility of Donor-specific Antibody Monitoring and the Role of Kidney Biopsy in Simultaneous Liver and Kidney Recipients With De Novo Donor-specific Antibodies.
Parajuli S; Aziz F; Blazel J; Muth BL; Garg N; Mohamed M; Rice J; Mezrich JD; Hidalgo LG; Mandelbrot D
Transplantation; 2021 Jul; 105(7):1548-1555. PubMed ID: 32732618
[TBL] [Abstract][Full Text] [Related]
33. The role of complement-fixing donor-specific antibodies identified by a C1q assay after heart transplantation.
Farrero Torres M; Pando MJ; Luo C; Luikart H; Valantine H; Khush K
Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28940521
[TBL] [Abstract][Full Text] [Related]
34. Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection.
Ginevri F; Nocera A; Comoli P; Innocente A; Cioni M; Parodi A; Fontana I; Magnasco A; Nocco A; Tagliamacco A; Sementa A; Ceriolo P; Ghio L; Zecca M; Cardillo M; Garibotto G; Ghiggeri GM; Poli F
Am J Transplant; 2012 Dec; 12(12):3355-62. PubMed ID: 22959074
[TBL] [Abstract][Full Text] [Related]
35. Technique and outcome of domino liver transplantation from patients with maple syrup urine disease: Expanding the donor pool for live donor liver transplantation.
Celik N; Kelly B; Soltys K; Squires JE; Vockley J; Shellmer DA; Strauss K; McKiernan P; Ganoza A; Sindhi R; Bond G; Mazariegos G; Khanna A
Clin Transplant; 2019 Nov; 33(11):e13721. PubMed ID: 31556146
[TBL] [Abstract][Full Text] [Related]
36. Progressive Fibrosis Is Driven by Genetic Predisposition, Allo-immunity, and Inflammation in Pediatric Liver Transplant Recipients.
Varma S; Ambroise J; Komuta M; Latinne D; Baldin P; Reding R; Smets F; Stephenne X; Sokal EM
EBioMedicine; 2016 Jul; 9():346-355. PubMed ID: 27333038
[TBL] [Abstract][Full Text] [Related]
37. Association of post-transplant donor-specific HLA antibody with liver graft fibrosis during long-term follow-up after pediatric liver transplantation.
Tokodai K; Miyagi S; Nakanishi C; Hara Y; Nakanishi W; Miyazawa K; Shimizu K; Murakami K; Sasano H; Goto M; Unno M; Kamei T
Pediatr Transplant; 2018 May; 22(3):e13169. PubMed ID: 29542229
[TBL] [Abstract][Full Text] [Related]
38. Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation.
Huang Y; Ramon D; Luan FL; Sung R; Samaniego M
Clin Transpl; 2012; ():247-56. PubMed ID: 23721029
[TBL] [Abstract][Full Text] [Related]
39. Protocol Biopsies in Patients With Subclinical De Novo Donor-specific Antibodies After Kidney Transplantation: A Multicentric Study.
Bertrand D; Gatault P; Jauréguy M; Garrouste C; Sayegh J; Bouvier N; Caillard S; Lanfranco L; Galinier A; Laurent C; Etienne I; Farce F; François A; Guerrot D
Transplantation; 2020 Aug; 104(8):1726-1737. PubMed ID: 32732853
[TBL] [Abstract][Full Text] [Related]
40. Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence.
Cherukuri A; Mehta R; Sharma A; Sood P; Zeevi A; Tevar AD; Rothstein DM; Hariharan S
Kidney Int; 2019 Jul; 96(1):202-213. PubMed ID: 31029504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
